Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 13.945 0.295 (2.16%) Market Cap: 1.34 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 19.10 GF Score: 43/100

Avadel Pharmaceuticals PLC at Jefferies Healthcare Conference (Virtual) Transcript

Jun 01, 2021 / 01:00PM GMT
Release Date Price: $7.93 (+3.12%)
Christopher Lawrence Howerton
Jefferies LLC, Research Division - Equity Analyst

Hi. Good morning, everybody, and welcome to the Virtual Jefferies Healthcare Conference. Very pleased to be hosting a fireside chat with the next company, Avadel. And on behalf of the company, we have both Greg, the CEO; and of course, Richard Kim, I believe the new joiner, right?

Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director

Thank you, Chris. Appreciate the opportunity to be here and spend some time together. Thank you.

Richard Kim
Avadel Pharmaceuticals plc - Chief Commercial Officer

Thank you.

Questions & Answers

Christopher Lawrence Howerton;Gregory J. Divis
Jefferies LLC, Research Division - Equity Analyst;Avadel

Absolutely. All right. So let's -- maybe let's just kind of level set here. So for those that are not totally familiar with the story, what is FT218? And what is the indication that you're trying to go after here?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot